cerrar
Tagged with

Sources of R&D Investment in Italy
The below chart shows the sources of funding for R&D investment in Italy, with only 7% of total investment originating from pharmaceutical and…

Italian Pharma SMEs: Family Knows Best!
Italy’s traditional family-owned pharmaceutical companies are one of its greatest strengths; but these companies must be amenable to outside…

Interview: Ti Hwei How – President, SAPI, Singapore
The Singapore Association of Pharmaceutical Industries' (SAPI) recently appointed president, Ti Hwei How highlights several unique attributes that…

Interview: Dr. Benjamin Seet – Executive Director, A*STAR BMRC,…
The executive director of A*STAR’s Biomedical Research Council, Dr. Benjamin Seet highlights several remarkable milestones that the organization has…

Home Care in France Stats
The chart below illustrates the potential for a shift in healthcare provision towards home care in France; a country with a rapidly increasing over 60…

French Dermo-Cosmetics: More than Skin Deep
France provides a unique environment for dermo-cosmetics companies such as Pierre Fabre, Uriage, and Galderma to thrive in terms of the industry's…

Interview: Roberto Martinez – General Director, OECD Mexico…
In light of the recently released OECD Reviews of Health Systems: Mexico 2016, Roberto Martinez, general director of the OECD Mexico Center for Latin…

The Philippines: Healthcare Opportunity Knocks
The expansion of universal healthcare coverage and significant growth in the use and acceptance of generics across the Philippines pose a significant…

Number of Clinical Trials in Italy
The following chart shows the number of clinical trials in Italy per year. Peaking in 2008 and slumping slightly shortly after, the numbers have…

Interview: Gabriel O’Shea – National Commissioner, Seguro…
Gabriel O’Shea, National Commissioner of Seguro Popular, on how the institute generates more efficient and transparent resource allocation across…

Italy Pharma Industry Factsheet
The following chart gives the key statistics on the Italian pharmaceutical industry; from number of manufacturing plants, to investments and export…

Interview: Francisco González Díaz – CEO, ProMéxico
Francisco González, CEO of ProMéxico, the Mexican investment agency, describes the strengths of Mexico’s research and industrial base, untapped…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here